Hepatitis C – New Treatment Option?

Hepatitis C is a disease that has been associated with a number of myths and some hard facts. While Hepatitis C patients fear getting treated because they have heard all sorts of horrific stories associated with HCV treatment, the question is: 'Can a Hepatitis C patient afford to stay away from the treatment and what will be the consequences if he or she decides to get treated? '. Also, what is the new treatment option, which was discovered in 2009, and since it is herbal, anyone can quickly apply it at home?

Hepatitis C patients who are confused if they should proceed with Hepatitis C treatment or not should consider if delaying will do them any good. The answer is an emphatic 'No!'. By using the new herbal treatment, anyone can get rid of the infection, quickly and without any side effects, without even going to a doctor.

Delay in treatment exposes patients infected with Hepatitis C virus to two dangerous liver diseases namely, fibrosis and cirrhosis. Although, it is in common knowledge that Hepatitis C is a liver disease but almost no details of the seriousness of the disease are in knowledge of those who are infected or are susceptible to getting infected with HCV.

Fibrosis is a liver condition in which scar tissue is formed on a person's liver. As a HCV infected patient suffers from inflammation of liver because of the virus, this can result in fibrosis if this inflammation continues for a long period. Formation of scars on our skin is a common phenomenon as often scars appear on our body as a result of injury. Although, scar tissue is protective in nature, it is not a perfect alternative to healthy skin as it has limited functions. The hepatitis c new treatment, avoids the fibrosis from forming, and cures the disease quickly.

Fibrosis is broadly split in two types, namely, pulmonary fibrosis and cystic fibrosis. While the later type is caused purely due to genetic complications, under the former type, that is, pulmonary fibrosis, patient's lung undergoes overgrowth and hardening of scars. In many studies HCV infected patients have been diagnosed with idiopathic pulmonary fibrosis which is a variation of this disease. Generally, patients suffering from pulmonary fibrosis display symptoms such as loss of appetite, fast weight loss, chronic dry cough, fatigue and discomfort in chest. Pulmonary fibrosis patients are generally expected to survive for up to 6 years after diagnosis